Viking Therapeutics
VKTX
#2117
Rank
S$10.12 B
Marketcap
$90.89
Share price
-0.54%
Change (1 day)
582.88%
Change (1 year)

Viking Therapeutics (VKTX) - Cash on Hand

Cash on Hand as of September 2024 : S$1.23 Billion

According to Viking Therapeutics 's latest financial reports the company has S$1.23 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viking Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.47 B129.41%
2022-12-31S$0.20 B-23.71%
2021-12-31S$0.27 B-16.85%
2020-12-31S$0.32 B-11.57%
2019-12-31S$0.37 B-9.79%
2018-12-31S$0.41 B1396.86%
2017-12-31S$27.51 M44.59%
2016-12-31S$19.03 M-4.6%
2015-12-31S$19.95 M1897.57%
2014-12-31S$0.99 M338.87%
2013-12-31S$0.22 M
2012-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.01 B-17.91%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.07 B-13.04%๐Ÿ‡บ๐Ÿ‡ธ USA